View Featured Offers >>
34200
PTMScan® Control Peptides O-GlcNAc
Proteomic Analysis Products
Cell Extracts
  1. Products
  2. Proteomic Analysis Products
  3. PTMScan® Control Peptides O-GlcNAc

PTMScan® Control Peptides O-GlcNAc #34200

Citations (0)
Annotated tandem mass spectrum (MS2) of the PTMScan® Control Peptides O-GlcNAc component: LATQSNEITIPVT(oglcnac)FES[R].  The ratio of the 138 m/z and 144 m/z ions supports the assignment of the GlcNAc oxonium ion to the peptide component, rather than the related GalNAc oxonium ion.
Annotated tandem mass spectrum (MS2) of the PTMScan® Control Peptides O-GlcNAc component: RQLFVT(oglcnac)VV[K]. The ratio of the 138 m/z and 144 m/z ions supports the assignment of the GlcNAc oxonium ion to the peptide component, rather than the related GalNAc oxonium ion.
Annotated tandem mass spectrum (MS2) of the PTMScan® Control Peptides O-GlcNAc component: VSTTAPVT(oglcnac)LASS[K]. The ratio of the 138 m/z and 144 m/z ions supports the assignment of the GlcNAc oxonium ion to the peptide component, rather than the related GalNAc oxonium ion.
Peptides included in the PTMScan® Control Peptides O-GlcNAc mix.  All peptides are stable-isotope labeled, designated by bracketed K or R, and contain an N-acetyl-glucosamine group designated by parentheses.
Extracted ion chromatograms of PTMScan® Control Peptides O-GlcNAc added at supplied concentration (1X at 200 fmol) to mouse liver peptides prior to enrichment using PTMScan® O-GlcNAc [GlcNAc-S/T] Motif Kit #95220.  Desalted peptides were analyzed on Q Exactive mass spectrometer and resolved using a 90 min reversed phase gradient from 7.5% to 32% acetonitrile on a C18 column.  The peak corresponding to the specific Control Peptide is marked with retention time and observed precursor mass, with peak height reported as the normalized level (NL) for each row per panel.
Image Gallery
Learn more about how we get our images

Product Usage Information

Use with Cell Signaling Technology’s PTMScan® kit protocol from the Immunoaffinity Purification (IAP) step.  Because the optimal amount of PTMScan® Control Peptides O-GlcNAc for each user’s experiments will depend on unique factors, such as mass spectrometer sensitivity, users may dilute these control peptides as needed.

1. Aliquot PTMScan® Control Peptides O-GlcNAc for storage as single-use units at -20°C or proceed to immediate usage.  
2. Resuspend sample peptides in the appropriate buffer and volume, e.g., 1.4 mL of PTMScan® IAP Buffer (1X).
3. Clear sample peptides by centrifugation.
4. Transfer clarified sample peptides to tubes containing IAP beads.
5. Add 10 µL of PTMScan® Control Peptides O-GlcNAc to IAP beads and sample peptides and mix well. 
6. Continue with PTMScan® or PTMScan® HS workflows at the 2-hour incubation step.
7. Detect PTMScan® Control Peptides O-GlcNAc in the LCMS data file.

Storage

This product is stable for 12 months when stored at -20°C. Aliquot to avoid multiple freeze/thaw cycles.

Product Description

The PTMScan® Control Peptides O-GlcNAc enable quality control of immunoaffinity enrichment performance using PTMScan® or PTMScan® HS workflows.  These synthetic peptides contain a specific post-translational modification (PTM) that can be enriched by the associated PTMScan® or PTMScan® HS immunoaffinity purification (IAP) beads, as well as a stable heavy isotope that can be distinguished from endogenous peptides by the mass spectrometer. 

Background

A distinct form of protein glycosylation, beta-linked N-acetyl-glucosamine (GlcNAc) moieties can be added to serine or threonine residues of proteins (1,2). This differs from other forms of glycosylation, as it typically is a single moiety rather than the complex branched sugars that are more commonly studied. It is thought that these modifications happen in a much more dynamic cycle more reminiscent of phosphorylation modifications. GlcNAc modified proteins are found in the cytoplasm and nucleus and are modulated by means of specific O-GlcNAc transferases (OGT) as well as GlcNAcase activity that can be inhibited using the Thiamet-G (TMG) inhibitor. Mass spectrometry analysis of this modification has been complicated due to the loss of the GlcNAc group during ionization and fragmentation, but methods and technologies such as electron transfer dissociation (ETD) are opening up new avenues to study these modifications. O-GlcNAc could play an important role in many cellular processes, including metabolism, growth, morphogenesis, apoptosis, transcription, and it may play a critical role in cancer (3).

Limited Uses

Except as otherwise expressly agreed in a writing signed by a legally authorized representative of CST, the following terms apply to Products provided by CST, its affiliates or its distributors. Any Customer's terms and conditions that are in addition to, or different from, those contained herein, unless separately accepted in writing by a legally authorized representative of CST, are rejected and are of no force or effect.

Products are labeled with For Research Use Only or a similar labeling statement and have not been approved, cleared, or licensed by the FDA or other regulatory foreign or domestic entity, for any purpose. Customer shall not use any Product for any diagnostic or therapeutic purpose, or otherwise in any manner that conflicts with its labeling statement. Products sold or licensed by CST are provided for Customer as the end-user and solely for research and development uses. Any use of Product for diagnostic, prophylactic or therapeutic purposes, or any purchase of Product for resale (alone or as a component) or other commercial purpose, requires a separate license from CST. Customer shall (a) not sell, license, loan, donate or otherwise transfer or make available any Product to any third party, whether alone or in combination with other materials, or use the Products to manufacture any commercial products, (b) not copy, modify, reverse engineer, decompile, disassemble or otherwise attempt to discover the underlying structure or technology of the Products, or use the Products for the purpose of developing any products or services that would compete with CST products or services, (c) not alter or remove from the Products any trademarks, trade names, logos, patent or copyright notices or markings, (d) use the Products solely in accordance with CST Product Terms of Sale and any applicable documentation, and (e) comply with any license, terms of service or similar agreement with respect to any third party products or services used by Customer in connection with the Products.

For Research Use Only. Not for Use in Diagnostic Procedures.
Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.
PTMScan is a registered trademark of Cell Signaling Technology, Inc.
All other trademarks are the property of their respective owners. Visit our Trademark Information page.
To Purchase # 34200
Cat. # Size Qty. Price
34200S		 100 µl  (10 assays)

Custom Formulation